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Abstract
Background: Increase in tissue factor (TF) and loss in thrombomodulin (TM) antigen levels has been described
in various inflammatory disorders. The functional consequences of such changes in antigen concentrations in the
coagulation balance are, however, not known. This study was designed to assess the consequences of
inflammation-driven organ specific functional properties of the procoagulant response.
Methods: Tissue specific procoagulant activity was assessed by adding tissue homogenate to normal human pool
plasma and recording of the thrombin generation curve. The new technique was subsequently applied on two
inflammation driven animal models: 1) mouse lipopolysaccharide (LPS) induced endotoxemia and 2)
spontaneously hypertensive rats exposed to environmental air pollution (particulate matter (PM).
Results: Addition of lung tissue from untreated animals to human plasma suppressed the endogenous thrombin
potential (ETP) (175 ± 61 vs. 1437 ± 112 nM.min for control). This inhibitory effect was due to TM, because a) it
was absent in protein C deficient plasma and b) lungs from TMpro/pro mice allowed full thrombin generation (ETP:
1686 ± 209 nM.min). The inhibitory effect of TM was lost after LPS administration to mice, which induced TF
activity in lungs of C57Bl/6 mice as well as increased the ETP (941 ± 523 vs. 194 ± 159 nM.min for control).
Another pro-inflammatory stimulus, PM dose-dependently increased TF in the lungs of spontaneously
hypertensive rats at 4 and 48 hours after PM exposure. The ETP increased up to 48 hours at the highest
concentration of PM (1441 ± 289 nM.min vs. saline: 164 ± 64 nM.min, p < 0.0001), suggesting a concentration-
and time dependent reduction in TM activity.
Conclusion: Inflammation associated procoagulant effects in tissues are dependent on variations in activity of
the TF-TM balance. The application of these novel organ specific functional assays is a useful tool to monitor
inflammation-driven shifts in the coagulation balance within animal or human tissues.
Published: 1 October 2008
Thrombosis Journal 2008, 6:14 doi:10.1186/1477-9560-6-14
Received: 24 May 2008
Accepted: 1 October 2008
This article is available from: http://www.thrombosisjournal.com/content/6/1/14
© 2008 Frederix et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Thrombosis Journal 2008, 6:14 http://www.thrombosisjournal.com/content/6/1/14
Page 2 of 11
(page number not for citation purposes)
Introduction
The inflammation associated procoagulant response is a
characteristic feature of innate immunity and a reflection
of the crosstalk between inflammation and blood coagu-
lation. During acute inflammatory conditions, such as
sepsis, the procoagulant response is characterized by
increased cellular expression of tissue factor (TF) [1-3], the
physiological trigger of coagulation. In addition, a loss of
endogenous anticoagulant activity is proposed to occur
during inflammation, mainly based on in vitro studies
showing loss in thrombomodulin (TM) and endothelial
protein C receptor (EPCR) antigen in cultured endothelial
cells [4-6]. In addition, incidental clinical studies have
documented reduced levels of circulating TM antigen dur-
ing bacterial sepsis [7].
In chronic inflammatory diseases, including atherosclero-
sis and cancer, increased expression of TF and reduced
expression of TM have also been observed [8-11]. In such
chronic conditions, a disturbed balance in pro- and anti-
coagulant activities is thought to have an unfavourable
effect on disease activity [11]. In atherosclerosis, increased
expression of TF and reduced anticoagulant activity may
stimulate thrombogenicity. In cancer, the loss of TM has
been linked to loss of cell differentiation, resulting in
increased tumour cell activity [12,13].
Recently, inflammation induced by environmental partic-
ulate air pollution (particulate matter: PM) has been
linked to chronic morbidity including cardiovascular and
lung disease, as well as mortality in several large clinical
studies [14-18]. The perturbation of the balance between
pro- and anticoagulant activity in organs exposed to PM,
however, may be a contributing factor to development of
disease.
Despite the knowledge about inflammation induced
changes in antigen levels of TM and TF, the overall func-
tional changes in pro- and anticoagulant activities have
not been studied. Since multiple factors are thought to be
involved in disorders as atherosclerosis, cancer, and PM
induced chronic lung disease, an overall analysis of
changes in the balance between pro- and anticoagulant
proteins would be helpful in assessing the net effects of
compounds that modulate inflammation and/or coagula-
tion. We therefore hypothesized that exposure to PM
stimulates blood coagulation by an indirect inflammation
mediated pathway, thereby disturbing the tissue factor/
thrombomodulin balance in favour of a procoagulant
phenotype.
To assess the procoagulant phenotype of tissues, e.g. the
balance between TF and TM activity, we first developed a
new functional assay in which the activity of both proteins
is indirectly determined through in vitro thrombin gener-
ation. Second, the method was validated using a mouse
endotoxemia model. Finally, the new method was applied
to study the PM induced procoagulant phenotype in a rat
model.
Materials and methods
Study design
Three different studies were undertaken to study the
effects of inflammation on tissue-specific hypercoagula-
bility: 1. Development of a new method to assess TF and TM
activity in tissue homogenates. In the first study a new
method was developed to determine the activities of TF
and TM within tissue homogenates. To this purpose, a
thrombin generation assay was modified to allow the
addition of tissue homogenates. 2. Validation of the new
method using a mouse endotoxemia model. The new devel-
oped method to determine the activities of TF and TM
within tissue homogenates was validated using a mouse
LPS-induced endotoxemia model. 3. Effects of particulate
matter on tissue factor activity and thrombin generation. The
inflammation-driven procoagulant effects of particulate
matter exposure on lung tissue were studied using a spon-
taneously hypertensive rat model.
Mouse strains and LPS-induced endotoxemia
C57Bl/J6 mice (Charles River, Someren, The Netherlands)
were used as wild type (WT) control mice as well as in the
LPS induced endotoxemia model. TMpro/pro mice carry a
single amino acid substitution (Glu404>Pro) in the TM
protein, which causes a reduced expression of TM and dis-
rupts the TM-dependent activation of protein C for almost
90% [19].
Endotoxemia was induced by intraperitoneal (i.p.) injec-
tion of 2 mg LPS (E. coli serotype O55:B5; Sigma-Aldrich,
St. Louis, MO) per kg bodyweight. After 6 hours, mice
were anaesthetized with 4% isoflurane and blood was
drawn from the vena cava after injection of 7 % of the
bodyweight 3.2% citrate buffer as described previously
[20]. Mice were perfused using St. Thomas cardioplegic
solution (University Hospital Maastricht, The Nether-
lands) through the portal vein for 10 minutes. Lung, liver,
heart, kidney, brain, and spleen were snap frozen in liquid
nitrogen. All mice were 10–12 weeks old and n = 6 mice
per group were used. All mice studies were approved by
the Animal Care and Use Committee of the Maastricht
University.
Rat experiments and particulate matter
Eleven to twelve weeks old spontaneously hypertensive
(SHR) male rats were exposed to PM by intratracheal
instillation [21]. In brief, rats were anaesthetized with 4%
halothane and road tunnel dust (RTD, solved in saline at
concentrations of 0.15, 0.5, 1.5 or 5 mg/ml) was instilled
in a volume of 2 ml/kg body weight to the final concen-Thrombosis Journal 2008, 6:14 http://www.thrombosisjournal.com/content/6/1/14
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trations of 0.3, 1, 3, and 10 mg/kg body weight [21]. In
addition, rats were instilled with either saline solution
(0.9% NaCl), or urban dust preparation EHC-93 (urban
dust PM sample collected from Environmental Health
Centre in 1993, Ottawa, Canada) at a final concentration
of 10 mg per kg body weight through a cannula inserted
into the trachea just above the bifurcation. Road tunnel
dust (RTD) and urban air PM sample (Ottawa dust; EHC-
93) were chemically characterized and described previ-
ously [21]. Briefly, RTD is an integrated PM sample, con-
sisting of coarse and fine fractions, collected at the exit of
a motorway tunnel at Hendrik-Ido-Ambacht (HIA). This
was collected on polyurethane foam (PUF) using a high
volume cascade impactor (HVCI) [22]. EHC-93, an urban
air PM sample recovered by vacuuming of bag-house fil-
ters of the Environmental Health Centre in Ottawa in
Canada was used as a second ambient PM sample. The
chemical composition and biological reactivity of EHC-93
have been described earlier [23,24].
Experiments were approved by the Animal Ethics Com-
mittee (IUCAC) of the Dutch National Vaccine Institute
(NVI), Bilthoven, The Netherlands.
Tissue preparation
Tissues were freeze dried for three days. The dried tissues
were pulverized using a small mortar and divided into two
portions for either mRNA isolation or protein analysis.
Fractions for protein analyses were dissolved in 50 mM n-
octyl β-D-glucopyranoside (Sigma-Aldrich) in HN-Buffer
(25 mM HEPES, 175 mM NaCl, pH 7.7), vortexed, and
centrifuged twice (10 min, 13000 rpm). Total protein con-
tent of the tissue homogenates was spectrophotometri-
cally determined using the Biorad DC Protein Assay
system according to the manufacturer's instructions (Bio-
Rad Laboratories B.V., Veenendaal, The Netherlands).
Thrombin-antithrombin (TAT) levels
Plasma levels of thrombin-antithrombin complexes
(TAT) were measured by a specific murine sandwich TAT
ELISA as described previously [20].
mRNA quantification
Total RNA was isolated using a Trizol method according
to the single-step method previously described [25], with
minor modifications (Sigma-Aldrich). Five to ten mg
freeze-dried tissue was dissolved in 1 mL Tri Reagent.
Samples were stored at -80° for precipitation steps, RNA
was washed with 80 %(v/v) ethanol and concentrations
were spectrophotometrically measured in RNase free
water. cDNA was synthesised using the Avian Enhanced
First Strand Synthesis kit (Sigma-Aldrich) according to the
manufacturer's instructions. mRNA levels for TF and TM
were measured on a Light cycler system 1.2 (Roche, Woer-
den, The Netherlands) using the SYBR premix Ex Taq kit
(Takara Bio Inc., Shiga, Japan) according to the manufac-
turer's instructions and using the following primers: TM
forward 5'-GTCACGGTCTCGACAG, TM reverse 5'-
GCAGCGTTTGAAAGTCC, TF forward 5'-GAAGAACAC-
CCCGTCG, and TF reverse 5'-GTTCGTCCTAACGTGACA.
Quantification was done relative to the household gene
glyceraldehyde 3 phosphate dehydrogenase (GAPDH)
using forward 5'-TCCCAGAGCTGAACGG and reverse 5'-
GAAGTCGCAGGAGACA primers.
Levels of TF and TM are expressed as ratios of TF/GAPDH
or TM/GAPDH and each data point represents an average
of 3 measurements.
Tissue factor activity measurement
TF activities in tissue homogenates were determined using
a home-made activity assay as previously described [26].
In brief, dissolved tissue homogenates with a concentra-
tion of 1 mg/mL total protein were diluted 20 times
(brain, lung and aorta) or 5 times (all other tissues) in
HN-buffer. A reference curve was prepared from Innovin
(Dade Behring Holding GmbH, Liederbach, Germany),
starting with 5 pM and diluted serially 7 times, also in HN
buffer. Samples were incubated for 45 minutes at 37°C in
the presence of recombinant factor VII (FVII) (Novo Nor-
disk, Bagsværd, Denmark), 0.2 mM 20/80 PS/PC vesicles,
1 U/mL Bovine factor X (Sigma-Aldrich) and 100 mM
Ca2+. The formation of factor Xa was then measured kinet-
ically using the chromogenic substrate S 2765 (Chromog-
enix, final concentration of 0.7 mg/mL diluted in 50 mM
Tris-HCl, 175 nM NaCl, 30 mM Na2EDTA, pH 7.4) by
measuring the OD at 405 nm each 15 seconds, for 15
minutes at 37°C.
Calibrated Automated Thrombogram
The Calibrated Automated Thrombogram (CAT,
Thrombinoscope, the Netherlands) was used to deter-
mine the contribution of mouse and rat tissue homoge-
nates to thrombin generation. We adapted the protocol
from the recording of thrombin generation curves in
platelet poor plasma as described previously [27]: 15 μl of
tissue homogenate (5 mg/mL total protein) was added to
80 μL of platelet poor pooled human plasma (normal
pool plasma, NPP) (University Hospital Maastricht),
which consisted of plasma from 80 healthy volunteers.
Thrombin generation was either triggered by adding 5 pM
TF, 4 μM phospholipids (PL) (TF/PL) and 16.7 mM Ca+2
to the reaction mixture, or without addition of TF/PL. In
the absence of additional TF/PL triggering of thrombin
generation depends entirely on procoagulant molecules,
such as TF, present in the tissue homogenate. Further-
more, activation of the coagulation cascade via the contact
system will occur in case no additional TF/PL are added
and TF is not present in the tissue homogenate added. The
following five parameters were derived from a thrombinThrombosis Journal 2008, 6:14 http://www.thrombosisjournal.com/content/6/1/14
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generation curve: lag time, time to peak, peak height, and
endogenous thrombin potential (ETP, the area under the
curve). The lag time is merely determined by TF and factor
VII, whereas both peak height and ETP are dependent on
fibrinogen, prothrombin, and antithrombin (Dielis,
Spronk et al. unpublished data). Both mouse and human
active site inhibited FVIIa were a kind gift of Dr. Petersen
(Novo Nordisk A/S, Denmark).
Statistical analysis
Data are presented as mean with standard deviation. Dif-
ferences between groups were assessed using non-paired
Student's t-test for normal distribution or Mann-Whitney
U test when distribution was not normal. P values < 0.05
were considered statistically significant. Statistical analy-
ses were performed using SPSS version 12.01 for Micro-
soft Windows.
Results
Development of a new method to assess TF and TM 
activity in tissue homogenates
To assess the overall procoagulant activity of various
organs, tissue homogenates were analyzed using an in
vitro  plasma-based fluorogenic thrombin generation
assay. This method uses TF (5 pM), phospholipids (PL, 4
μM) (the so called PPP-reagent), and CaCl2 (16.7 mM) to
trigger thrombin generation in platelet-poor human
plasma. From the resulting thrombin generation curve
several parameters can be derived, including the lag time
(defined as the time to reach 1/6 of the maximum
thrombin formed), the peak height (the maximum
amount of thrombin formed), and the area under the
curve, also known as the endogenous thrombin potential
(ETP). For normal human pool plasma a lag time of
thrombin generation of 2.56 ± 0.09 min and an ETP of
1592 ± 67 nM.min were observed.
Modification of this method consisted of the addition of
normal mice tissue homogenate to platelet-poor human
plasma, along with the additional reagent (5 pM TF, 4 μM,
16.7 nM CaCl2) to trigger thrombin generation. By doing
so, addition of lung homogenate (ETP: 194 ± 159
nM.min) caused a 8-fold reduction in thrombin genera-
tion compared to platelet-poor human plasma alone
(ETP: 1591 ± 67 nM.min, p < 0.01, Figure 1, Panel A). Fur-
thermore, compared to platelet-poor human plasma
alone heart homogenate (ETP: 874 ± 75 nM.min, p <
0.01) attenuated thrombin generation, whereas the addi-
tion of brain (ETP: 1802 ± 43 nM.min), kidney (ETP:
1631 ± 81 nM.min), liver (ETP: 1631 ± 49 nM.min), or
spleen (ETP: 1298 ± 202 nM.min) had no significant
influence (Figure 1F, white bars).
As stated before, thrombin generation dependents on the
addition of TF, PL, and Ca2+, although in the presence of
only PL and Ca2+, thrombin generation can occur as a
result of contact activation, which is characterized by a
long lag time before thrombin generation (>10 minutes).
If, however, tissue homogenates were added without
additional TF, PL, and Ca2+, thrombin generation in plate-
let-poor human plasma became dependent on the pres-
ence of TF and PL within the added tissue homogenate.
Upon addition of mouse tissue homogenates to plasma,
thrombin generation in the absence of additional TF, PL,
and Ca2+, showed considerable variation in lag times and
ETPs compared to analysis in the presence of TF, PL, and
Ca2+ (Figure 1B, E, and 1F). The short lag times observed
for the thrombin generation curves after addition of lung,
brain, and kidney were comparable between analysis in
the presence or absence of additional TF, PL, and Ca2+
(Figure 1E), suggesting that sufficient amounts of TF were
present in these tissues to trigger thrombin generation.
These findings are compatible with the notion that the
constitutive concentrations of TF are high in brain and
lung, which is in agreement with the observed TF activity
in the chromogenic assay (Figure 2). In contrast, liver (Fig-
ure 1B) and heart produced markedly prolonged lag times
in the absence of additional TF, PL, and Ca2+, as compared
to lung, brain, and kidney (Figure 1E), indicating low TF-
concentrations in these homogenates and suggesting that
contact activation triggered thrombin generation. This
was supported by the observation that no thrombin gen-
eration was observed in the presence of the coagulation
factor XIIa inhibitor corn trypsin inhibitor (CTI), or when
FXII-deficient plasma was used instead of normal plasma
(data not shown). The strongest overall procoagulant
effect, expressed as ETP, was observed for liver, brain, and
kidney, while lung and heart hardly induced any
thrombin generation (Figure 1D). Kidney, liver, and
spleen homogenates also initiated thrombin generation,
as indicated by the ETP-values (Figure 1D), despite the
rather low levels of endogenous TF (Figure 2).
To ensure that murine TF activity was indeed an important
determinant of thrombin generation in platelet-poor
human plasma, a separate experiment was performed in
which active site inhibited factor VIIa (ASIS) was added to
plasma containing mouse lung homogenate. In all cases,
both human and murine ASIS prolonged the lag time
dose dependently, impairing thrombin generation com-
pletely at the highest dose of ASIS (data not shown), dem-
onstrating that TF from mouse tissue homogenates
triggers thrombin generation in platelet-poor human
plasma and that species specificity is not a limitation in
this new method.
Overall, despite the presence of relatively large amounts
of endogenous TF (Figure 2: TF activity in lung homoge-
nate and Figure 1B lag times from thrombin generation
analysis in the presence of lung homogenate) thrombinThrombosis Journal 2008, 6:14 http://www.thrombosisjournal.com/content/6/1/14
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Influence of lung and liver tissue homogenate on thrombin generation in plasma Figure 1
Influence of lung and liver tissue homogenate on thrombin generation in plasma. Lung (light grey curve) or liver 
(dark grey curve) homogenates were added to human normal plasma with additional TF (5 pM) and PL (4 μM) (Panel A) or in 
the absence of additional TF and PL (Panel B). For comparison, thrombin generation in human normal plasma triggered with 5 
pM TF and 4 μM PL is plotted (white curve) in panels A, B, C, and DPanel C: Addition of lung (light grey curve) or liver (dark 
grey curve) homogenate to protein C deficient plasma (Panel C) in the presence of additional TF/PL. Panel D: Addition of lung 
(light grey curve) or liver (dark grey curve) homogenates from TMpro/pro transgenic animals to platelet-poor human plasma. 
Panels E and F: overview of the lag time and ETP derived from thrombin generation curves for tissue homogenates added to 
platelet-poor human plasma in de absence of additional TF/PL (white bars) or in the presence of additional TF/PL (black bars), 
tissue homogenates added to protein C-deficient plasma (grey bars), and tissue homogenates from TMpro/pro transgenic ani-
mals to platelet-poor human plasma (hatched bars). Bars represent mean ± SD from 6 tissue homogenates.Thrombosis Journal 2008, 6:14 http://www.thrombosisjournal.com/content/6/1/14
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generation with addition of lung homogenate was
reduced for both the analysis with and without addition
of TF, PL, and Ca2+. These results suggested the presence of
one or more inhibitors in lung and heart tissue with
potential factors being glycosaminoglycans, components
of the protein C pathway, or tissue factor pathway inhibi-
tor (TFPI). While the latter cannot be ruled out with cer-
tainty, heparinase treatment of lung homogenates did not
influence the inhibitory effect of lung tissue on thrombin
generation (data not shown), suggesting no influence of
endogenous glycosaminoglycans. Measuring thrombin
generation in protein C-deficient human plasma, how-
ever, resulted in increased thrombin generation (e.g.
higher ETP values compared to normal human pool
plasma) after addition of lung homogenate (ETP: 1818 ±
176 nM.min), indicating that the observed reduction in
thrombin generation after addition of lung homogenate
to plasma was most likely dependent on a component of
the protein C pathway (Figure 1C and 1F grey bars). The
same was true for the addition of heart homogenate (ETP:
1619 ± 35 nM.min) (Figure 1F).
Since TM is one of the key factors in protein C activation
we next analyzed organ homogenates from TMPro/Pro ani-
mals which carry a single amino acid functional mutation
in the thrombin binding domain that markedly dimin-
ishes the protein C cofactor activity of TM [19]. Thrombin
generation in normal pool plasma with addition of TMpro/
pro organs was comparable to levels obtained for human
plasma alone (lung ETP: 1686 ± 209 nM.min, heart ETP:
1767 ± 200 nM.min, liver ETP: 2017 ± 66 nM.min), as
well as wild-type organs added to protein C-deficient
plasma (Figure 1D), indicating the presence of active TM
in lung and heart homogenates. On the basis of these data
it is likely that the inhibitory effect of specific organs in the
thrombin generation assay is due to functionally active
TM.
Validation of the new method using a mouse endotoxemia 
model
To validate the new functional method for TF and TM
activity in murine tissues a LPS-induced endotoxemia
mouse model was used. One of the key characteristics of
TF activity in tissue homogenates before (white bars) and 6 hours after LPS administration (grey bars) Figure 2
TF activity in tissue homogenates before (white bars) and 6 hours after LPS administration (grey bars). Tissue 
factor activity in brain, lung, heart, spleen, liver and kidney homogenates were measured at a total homogenate protein concen-
tration of 1 mg/ml. Bars indicate mean ± SD of n = 6 animals per groups. * denotes p < 0.05.Thrombosis Journal 2008, 6:14 http://www.thrombosisjournal.com/content/6/1/14
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LPS-induced endotoxemia is the activation of coaguka-
tion as well as increased TF expression in lung tissue. Acti-
vation of coagulation upon LPS-induced endotoxemia
was confirmed by measuring thrombin-antithrombin
(TAT) complex levels 6 hours after lipopolysaccharide
(LPS)-treatment of C57Bl/6 mice. LPS-stimulated mice
showed a 20-fold increase in plasma TAT-levels (204.8 ±
123.3 ng/mL), compared to non-treated control animals
(9.2 ± 7.7 ng/mL, p < 0.0001).
To determine the procoagulant activity of LPS challenge at
the organ level we compared TF activities in different
organs from endotoxemic and control mice (Figure 2): TF
activity in lungs of endotoxemic animals (25.8 ± 5.3 pM)
was significantly higher than in lungs of control mice
(12.7 ± 1.7 pM, p < 0.05), whereas the activity in other
organs was comparable between both groups (Figure 2).
In accordance, TF mRNA levels in lung tissue were signif-
icantly increased after endotoxemia (1.8 ± 0.1 vs. 1.4 ±
0.3, p < 0.02; Figure 3A), whereas the levels in other
organs such as the heart (0.07 ± 0.03, Figure 3B) remained
at a level comparable to controls (0.10 ± 0.03, p > 0.1) as
expected.
Comparing thrombin generation curves recorded in either
the presence or the absence of TF, PL, and Ca2+, demon-
strated a significant induction of thrombin generation for
lung homogenates from mice subjected to LPS challenge
(ETP: +TF: 940 ± 523, -TF: 692 ± 369 nM.min, Figure 4A),
compared to controls (ETP: +TF:194 ± 159 nM.min, -TF:
103 ± 83 nM.min, p < 0.01, Figure 1F). These results are
suggestive of attenuated inhibitory potential (e.g.
decreased TM levels) or increased TF activity in lung tissue
due to endotoxemia. The opposite influence of LPS was
observed for heart tissue, which in the absence of PPP-rea-
gent showed a significantly prolonged lag time after LPS
challenge (15 ± 4 min, Figure 4C) compared to control
heart tissue (11 ± 1 min, p < 0.05, Figure 4C). This later
observation suggest decreased TF expression in the heart
upon LPS induced inflammation, as observed previously
by Luther et al. [28].
No changes were observed for brain (ETP: +TF 1795 ± 49
nM.min, -TF: 1488 ± 57 nM.min) and heart (ETP: +TF:
785 ± 90 nM.min, -TF: 179 ± 58 nM.min) (Figure 4D)
from LPS-treated animals compared to control tissues
(Brain ETP: +TF 1802 ± 43 nM.min, -TF: 1434 ± 60
nM.min; Heart ETP: +TF: 874 ± 74 nM.min, -TF: 144 ± 31
nM.min)(Figure 1F). Note that analyses were done both
in the presence (+TF) and absence (-TF) of additional TF.
The increased thrombin generating activity of lung tissue
after LPS treatment is suggestive for reduced availability of
TM in the tissue homogenate, based on the aforemen-
tioned dependence of thrombin generation inhibition by
TM in tissue; this conclusion is supported by the observed
reduced TM mRNA expression in lung after LPS challenge
(0.16 vs. 0.03, p < 0.01, Figure 3C). In contrast, we could
not detect TM mRNA in other tissues.
Effects of particulate matter on the procoagulant balance 
in lung tissue
Recent data showed enhanced expression of TF mRNA in
lungs of spontaneously hypertensive rats after exposure to
PM [29]. Here, we analyzed the pro- and anticoagulant
activity in rat lung tissue at different time points (4 and 48
hours) after exposure to two types of PM: road tunnel dust
(RTD) and urban dust (EHC-93). At 4 and 48 hours after
TF (panels A and B) and TM (panel C) mRNA levels before (open circles) and 6 hours after LPS administration (filled circles) in  lung (panel A and C) and heart (panel B) Figure 3
TF (panels A and B) and TM (panel C) mRNA levels before (open circles) and 6 hours after LPS administration 
(filled circles) in lung (panel A and C) and heart (panel B). mRNA levels are expressed as a ratio to GAPDH. Each dot 
represents the average of a triplicate measurement within one mouse. Horizontal lines indicate the mean expression level and 
* denotes p < 0.05.Thrombosis Journal 2008, 6:14 http://www.thrombosisjournal.com/content/6/1/14
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exposure to RTD, TF activities in lungs showed a trend to
increase with increasing concentrations of RTD. TF activity
was significantly increased at the highest concentration of
PM (10 mg RTD per kg BW) compared to saline instilla-
tion (at 4 hours: 1045 ± 472 pM vs. 397 ± 231 pM) (Figure
5). No differences in TF activity were observed between
saline and EHC-93 (10 mg/kg) instillation at 4 hours after
exposure (587 ± 260 pM), whereas TF activity was mark-
edly increased (1870 ± 693 pM, p < 0.01) at 48 hours after
exposure.
Thrombin generation (Table 1) was increased with rising
concentrations of PM, with the difference between the
dose of 10 mg/kg BW and saline control being significant
at 4 hours (RTD: ETP 390 ± 148 nM.min, EHC-93: ETP
264 ± 64 nM.min vs. saline: ETP 186 ± 80 nM.min, p <
0.01) and 48 hours (RTD: ETP 1441 ± 289 nM.min, EHC-
93: ETP 1719 ± 103 nM.min vs. saline: ETP 174 ± 61
nM.min, p < 0.0001). The increase in thrombin genera-
tion at 48 hours compared to 4 hours (with almost equal
TF activities and lag times) strongly suggests a loss in TM
activity at the 48 hrs time point.
Discussion
The interaction between coagulation and inflammation is
a bidirectional process and the protein C pathway as well
as TF plays key roles in this crosstalk [30,31]. In order to
characterize the functional heterogeneity of procoagulant
responses to inflammation in vivo, we undertook initial
experiments in mice challenged with LPS, a commonly
used inflammatory agonist. Endogenous as well as
induced TF activities were relatively high in organs such as
Influence of LPS on thrombin generation triggered with additional TF (5 pM) and PL (4 μM) (open curves and bars) or without  (grey curves and bars) Figure 4
Influence of LPS on thrombin generation triggered with additional TF (5 pM) and PL (4 μM) (open curves and 
bars) or without (grey curves and bars). Panel A and B: Typical thrombin generation curves recorded from normal human 
plasma in the presence of lung (A) or liver (B) homogenate 6 hours after LPS administration. White curve (❍): control lung tis-
sue without TF/PL. Grey curve (): lung tissue after LPS-treatment without TF/PL. Black curve (): lung tissue after LPS-treat-
ment with TF/PL. Panel C and D: Lag times (C) and ETPs (D) derived from the thrombin generation curves recorded for 
normal human plasma in the presence of organ homogenates 6 hours after LPS administration. Bars represent mean ± SD from 
6 tissue homogenates.Thrombosis Journal 2008, 6:14 http://www.thrombosisjournal.com/content/6/1/14
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the brain and lungs and relatively low in organs like heart
and liver, with a marked positive response in TF activity in
the lungs 6 hrs after LPS challenge, which may be
explained by increased production, as also indicated by
the mRNA data. Expecting a procoagulant effect of organ-
derived TF we tested the different mouse organs in a
thrombin generation assay using human plasma as a
source of prothrombin and other coagulation factors. We
observed a marked heterogeneity in thrombin potentials,
with the highest thrombin generation in brain, kidney
and liver. An organ-dependent effect was observed, with
as surprising observation the inhibitory effect of lung tis-
sue on thrombin generation in plasma. Further experi-
ments showed that this inhibitory effect of lung tissue was
based on functional TM, as indicated by the fact that it was
neutralized in protein C-deficient plasma as well as by
replacement of wild type by TMPro/Pro lung tissue. Subse-
quent studies showed that the TM-associated activity was
virtually lost after LPS infusion, demonstrating for the first
time the functional loss in natural anticoagulant function
in vivo.
Pro-inflammatory cytokines down regulate TM and EPCR
in cultured endothelial cells [32] and our data show a sup-
pression of TM mRNA in lung tissue. We were not able to
detect significant TM mRNA levels in other tissues to doc-
ument similar changes there, which may be related to
density of endothelial cells and corresponding low
amounts of mRNA. At the protein level there is clinical
evidence for loss of circulating TM antigen levels and in
TF activity in rat lung homogenates after 4 (white bars) and 48 hours (grey bars) exposure to PM Figure 5
TF activity in rat lung homogenates after 4 (white bars) and 48 hours (grey bars) exposure to PM. Road tunnel 
dust (RTD) at final concentrations of 0.3, 1, 3, and 10 mg/kg BW was compared to saline, and EHC-93 at a final concentration 
of 10 mg/kg BW. Total protein concentration of the samples was 1 mg/ml. Bars indicate mean ± SD of n = 2 × 6 animals per 
group. * denotes p < 0.05.Thrombosis Journal 2008, 6:14 http://www.thrombosisjournal.com/content/6/1/14
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the microvascular endothelium of children with menin-
gococcal sepsis, which may be due to a combination of
down regulation, release, and proteolysis [33,34]. Our
data indicate that indeed, TM activity disappears from the
pulmonary compartment although we cannot determine
the reasons for this loss, other than diminished gene tran-
scription. In the absence of antigen assays specific for
mouse or rat TM we were not able to show concurrent
changes in TM antigen levels.
Next we employed the coagulation activity assays to
address the pro-inflammatory effects of PM in rats. This
fraction of environmental pollutants has been associated
with a number of pro-inflammatory effects in animal [23]
and human cell culture [35] studies. In an unbiased search
for mediators of PM induced inflammation in the lung
Kooter and colleagues established among a panel of dif-
ferentially expressed genes, an abundant expression of TF
[29], which formed the basis for the present activity stud-
ies. Our data demonstrate that pulmonary instillation of
PM induced TF activity as well as concurrent loss of TM
associated activity in a concentration dependent manner.
An increased TF and decreased TM activity in lungs, with-
out being able to specify the cells involved, may contrib-
ute to a prothrombotic state, but more importantly
increased amounts of thrombin that are less effectively
quenched by TM, may facilitate increased interactions
with other endothelial cell receptors including the family
of G protein-coupled protease-activated receptors (PARs)
[36]. Thrombin-mediated PAR signaling on endothelial
cells results in a coordinated combination of responses
and together with the reported anti-apoptotic [37] and
pro-angiogenic [38] roles the cellular actions suggest that
thrombin links haemostatic and inflammatory actions to
vascular remodeling and angiogenesis.
The strength of our approach is that in contrast to previ-
ous studies we have addressed the functional changes,
instead of the alteration in antigen levels, in coagulation
activity inflicted by pro-inflammatory mediators in tissues
from mouse and rat. Using the present procedures we
were not able to distinguish which cell types express the
observed pro- or anticoagulant activities. For instance, in
the lung vascular cells including endothelial cells and
smooth muscle cells may be largely responsible for the
effects of TM, while to a lesser extent TF may be expressed
by these cells. Epithelial cells may also contribute to TF
expression. In the future the utilized assays may well be
applied on tissue sections or isolated cells to address the
issue of localization of pro- and anticoagulant activities.
In conclusion, the combination of assays for TF and
thrombin generation revealed organ variability in proco-
agulant responses to specific inflammatory stimuli, indi-
cated by alterations in TF and TM activities within the
same organ. We showed that PM, a critical component of
the industrialized environment, induced procoagulant
activity in the lungs, which may ultimately contribute to
pulmonary and cardiovascular disease.
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Table 1: Influence of particulate matter exposed rat lung on the 
endogenous thrombin potential (ETP) in thrombin generation.
Treatment ETP at 4 hrs
(nM.min)
ETP at 48 hrs
(nM.min)
0.3 mg RTD/kg 231 ± 105 103 ± 77
1 mg RTD/kg 264 ± 102 154 ± 128
3 mg RTD/kg 324 ± 102 288 ± 119
10 mg RTD/kg 390 ± 148* 1164 ± 199#
10 mg EHC-93/kg 264 ± 64* 1449 ± 32#
0.9% NaCl 175 ± 61 116 ± 60
RTD: Road tunnel dust environmental air pollution, EHC-93: urban 
dust environmental air pollution. * denotes significant difference 
compared to 0.9% NaCl treatment at 4 hrs. # denotes significant 
difference compared to 0.9% NaCl treatment at 48 hrs.Publish with BioMed Central    and   every 
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